First Time Loading...
V

Vor Biopharma Inc
NASDAQ:VOR

Watchlist Manager
Vor Biopharma Inc
NASDAQ:VOR
Watchlist
Price: 1.74 USD 3.57% Market Closed
Updated: May 16, 2024

Cash Flow Statement

Cash Flow Statement
Vor Biopharma Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Net Income
(19)
(23)
(32)
(43)
(49)
(60)
(66)
(69)
(78)
(81)
(86)
(92)
(98)
(106)
(116)
(118)
(120)
Depreciation & Amortization
0
0
0
1
1
1
1
1
2
2
2
3
3
3
3
3
4
Stock-Based Compensation
0
0
1
1
2
3
4
4
5
6
8
11
13
16
15
13
0
Other Non-Cash Items
1
1
1
2
3
5
6
7
9
10
13
17
19
19
17
13
12
Change in Working Capital
2
(0)
2
4
(3)
(3)
(6)
(9)
(7)
(13)
(13)
(13)
(11)
(2)
0
1
(2)
Cash from Operating Activities
(16)
N/A
(23)
-45%
(28)
-23%
(36)
-28%
(48)
-32%
(56)
-17%
(65)
-16%
(69)
-6%
(74)
-8%
(83)
-11%
(84)
-2%
(85)
-1%
(87)
-2%
(86)
+1%
(95)
-11%
(100)
-6%
(106)
-6%
Investing Cash Flow
Capital Expenditures
(1)
(2)
(3)
(4)
(5)
(5)
(4)
(4)
(5)
(10)
(9)
(8)
(7)
(1)
(1)
(1)
(1)
Other Items
0
0
0
0
0
(75)
(83)
(88)
(93)
(15)
6
(86)
(74)
(63)
(35)
72
110
Cash from Investing Activities
(1)
N/A
(2)
-27%
(3)
-68%
(4)
-50%
(5)
-15%
(80)
-1 579%
(87)
-9%
(92)
-5%
(98)
-6%
(24)
+75%
(3)
+88%
(94)
-3 036%
(81)
+14%
(64)
+20%
(36)
+43%
71
N/A
108
+53%
Financing Cash Flow
Net Issuance of Common Stock
35
82
82
83
299
235
235
235
1
1
5
117
120
120
116
4
1
Other
0
0
0
0
(2)
(2)
(2)
(2)
(0)
0
0
0
(1)
(1)
(1)
(1)
0
Cash from Financing Activities
35
N/A
82
+131%
82
+1%
83
+0%
298
+261%
233
-22%
233
0%
233
+0%
0
-100%
1
+404%
5
+296%
117
+2 157%
119
+2%
119
0%
115
-3%
3
-97%
1
-83%
Change in Cash
Net Change in Cash
18
N/A
57
+214%
51
-10%
42
-18%
245
+482%
97
-61%
80
-17%
72
-10%
(172)
N/A
(106)
+38%
(82)
+22%
(62)
+24%
(48)
+23%
(31)
+35%
(16)
+49%
(26)
-67%
3
N/A
Free Cash Flow
Free Cash Flow
(17)
N/A
(25)
-43%
(31)
-26%
(40)
-30%
(53)
-30%
(61)
-16%
(69)
-13%
(73)
-5%
(79)
-8%
(92)
-17%
(94)
-1%
(94)
+0%
(93)
+1%
(87)
+7%
(96)
-11%
(101)
-6%
(108)
-6%

See Also

Discover More